Radiation oncology consult · Clinical Notes
Radiation oncology consult
Sep 8, 2026 · R. Lee, MD · 1 page
G2 › Whitfield, Dell › Clinical Notes › 2026-09-08 Radiation oncology consult
cT2a N0 M0, PSA 6.2 ng/mL, favorable intermediate risk.C-3
Dell Whitfield
Needs a human
71 M · MRN TCPT-0047120 · Prostate adenocarcinoma, favorable intermediate risk, cT2a N0 M0
VA Community Care Network Community Care (Federal (VA)) · VA CCN 4471-208-11
Ordered by R. Lee, MD · Sep 15, 2026 · CPT 77523 · C61 Malignant neoplasm of prostate